Clonal anergy is a state in which T cells or B cells remain alive but respond weakly, or fail to respond, after recognizing an antigen. It is an important mechanism of immune tolerance, particularly peripheral immune tolerance, that restrains self-reactive lymphocytes without immediately eliminating them. “Clonal” refers to lymphocytes sharing an antigen-receptor specificity; it does not mean that the entire immune system becomes inactive. Anergy involves altered signaling or gene regulation within the affected cells rather than simply an absence of stimulation. (sciencedirect.com)
Definition and experimental origins
Anergy is an acquired functional condition, not a separate lymphocyte lineage. Its defining feature is reduced responsiveness on subsequent stimulation under conditions that would activate comparable responsive cells. In classical T-cell experiments, the principal defects are diminished interleukin-2 production and reduced proliferation. Other cytokine responses may also decline, but not necessarily to the same extent. Thus, anergy does not imply complete loss of every cellular function. (pubmed.ncbi.nlm.nih.gov)
An influential 1987 study by Marc Jenkins and Ronald Schwartz demonstrated antigen-specific T-cell unresponsiveness after antigen presentation by chemically modified spleen cells. These experiments helped establish the distinction between antigen recognition and the additional signals required for productive activation. Subsequent work showed that some experimentally anergized T-cell clones could recover responsiveness, demonstrating that anergy need not be irreversible. (rupress.org)
Induction in T cells
T cells recognize antigen through the T-cell receptor, usually as peptides associated with major histocompatibility complex molecules on an antigen-presenting cell. Productive activation depends on more than receptor engagement: T-cell costimulation and the surrounding signaling environment influence the outcome. In classical experimental systems, receptor stimulation without adequate costimulation can induce anergy rather than sustained proliferation and cytokine production. This is a model of signal integration, not a rule that every encounter lacking costimulation necessarily produces anergy. (rupress.org)
A major molecular pathway involves calcium-dependent activation of calcineurin and the nuclear factor of activated T cells, NFAT. NFAT is a transcription factor that participates in both activation and tolerance. During productive activation, it cooperates with AP-1, a transcription-factor complex containing Fos and Jun proteins. When NFAT activity is insufficiently balanced by AP-1, it can promote a different program of gene expression associated with hyporesponsiveness. (sciencedirect.com)
Experiments manipulating NFAT interactions have shown that distinct NFAT-containing complexes regulate tolerance-associated genes. NFAT dimers, for example, can contribute to anergy induction. These findings explain why anergy is an actively established cellular state: antigen recognition can initiate a program that subsequently limits receptor signaling and cytokine responses, rather than merely failing to switch the cell on. (pmc.ncbi.nlm.nih.gov)
Anergy in B cells
B-cell anergy restrains cells whose immunoglobulin receptors recognize self-antigens. Such cells may persist in the peripheral repertoire while showing attenuated receptor signaling and reduced activation. The phenomenon is therefore distinct from deleting every self-reactive clone. In humans, researchers have identified a mature naive B-cell population with little or no detectable surface IgM but retained IgD; these cells were enriched for self-reactive receptors and displayed functional hyporesponsiveness. This observation provides evidence that B-cell anergy is not confined to engineered mouse systems. (pmc.ncbi.nlm.nih.gov)
Maintenance can require continuing self-antigen exposure. In one immunoglobulin-transgenic mouse model, experimentally displacing self-antigen from receptors rapidly reversed several anergic features and restored antigen responsiveness. The result demonstrates a continuously maintained state in that model, rather than a permanent memory of an earlier tolerizing encounter. (nature.com)
Inhibitory signaling also contributes directly. Mouse experiments using inducible genetic changes showed that both SHP-1 and SHIP-1 phosphatase pathways were required to maintain B-cell unresponsiveness. Disrupting these pathways allowed previously anergic cells to activate, proliferate, and generate short-lived autoantibody responses. Such findings connect anergy to protection against autoimmunity, while remaining specific to the experimental systems studied. (pmc.ncbi.nlm.nih.gov)
Distinction from related states
Anergy differs from clonal deletion, in which antigen-reactive cells are physically removed, commonly through apoptosis. It also differs from suppression by regulatory T cells: anergy describes impaired responsiveness within the target lymphocyte, whereas suppression involves restraint imposed by other cells. These mechanisms can interact; regulatory cells can create conditions that favor dysfunctional responses in neighboring lymphocytes. (pmc.ncbi.nlm.nih.gov)
T-cell exhaustion is another form of impaired responsiveness, typically associated with persistent antigen stimulation. It overlaps molecularly with anergy, including NFAT-dependent programs, but the terms are not interchangeable. Experiments in activated CD8 T cells showed that NFAT activity lacking AP-1 cooperation could induce features associated with both states, illustrating shared regulatory machinery without establishing that they are identical. (pmc.ncbi.nlm.nih.gov)
Assessment and biological significance
Researchers assess anergy through functional comparison: receptor stimulation, cytokine production, proliferation, calcium responses, and expression of activation-associated molecules. Cell survival must be considered because a weak population-level response can otherwise reflect cell loss rather than functional silencing. Surface phenotype alone is insufficient; the human B-cell studies combined receptor-expression patterns with direct measurements of attenuated signaling. (pubmed.ncbi.nlm.nih.gov)
Reversibility depends on context. Added interleukin-2 reversed anergy in a classical mouse helper-T-cell clone model, whereas antigen displacement restored responsiveness in the B-cell model described above. Anergy has also been investigated in cancer: mouse tumor studies identified NFAT1-dependent CD4 T-cell hyporesponsiveness that contributed to immune escape. These results establish mechanistic roles in particular models, not a universal explanation for tumor-associated immune dysfunction. (pubmed.ncbi.nlm.nih.gov)